-- Days : -- HRS : -- MIN : -- SEC

Register Now →

Subscribe

News
Video
Podcasts
Journals
Conferences
Events
Resources
CE
About AJMC
Subscribe

Spotlight -

Free In-Person Regional Events Focused on Oncology and Population Health

|Videos|April 29, 2019

The Future of Migraine Prevention and Treatment

Episodes in this series

EP. 1 Defining and Diagnosing Migraine

EP. 1 Defining and Diagnosing Migraine

EP. 2 The Burden of Migraine in the US

EP. 2 The Burden of Migraine in the US

EP. 3 Navigating Barriers to Access Preventive Migraine Drugs

EP. 3 Navigating Barriers to Access Preventive Migraine Drugs

EP. 4 Medication Overuse and Misuse in Patients With Migraine

EP. 4 Medication Overuse and Misuse in Patients With Migraine

EP. 5 Reducing Migraine-Specific Medication Treatment Days

EP. 5 Reducing Migraine-Specific Medication Treatment Days

EP. 6 Targeting CGRP for the Prevention of Episodic Migraine

EP. 6 Targeting CGRP for the Prevention of Episodic Migraine

EP. 7 Criteria for Coverage of CGRP Antagonists in Migraine

EP. 7 Criteria for Coverage of CGRP Antagonists in Migraine

EP. 8 Attaining Approval of Drugs for Prevention of Migraine

EP. 8 Attaining Approval of Drugs for Prevention of Migraine

EP. 9 Real-World Patients Treated With CGRPs for Migraine

EP. 9 Real-World Patients Treated With CGRPs for Migraine

EP. 10 New Data for the Prevention of Chronic Migraine

EP. 10 New Data for the Prevention of Chronic Migraine

EP. 11 Reclassification From Chronic to Episodic Migraine

EP. 11 Reclassification From Chronic to Episodic Migraine

EP. 12 The Future of Migraine Prevention and Treatment

EP. 12 The Future of Migraine Prevention and Treatment

Transcript:

Newsletter

Stay ahead of policy, cost, and value—subscribe to AJMC for expert insights at the intersection of clinical care and health economics.

Trending on AJMC

Early Treatment Succeeds in CRC With Next Generation KRAS Inhibitor Calderasib Plus Cetuximab Combo

Tec-Dara Shows MRD-Negative, PFS Benefit in High-Risk Myeloma, But Longer Follow-Up Needed: Rahul Banerjee, MD

emtelligent Turns Unstructured Clinical Data Into Actionable Insights

Adam Kittai, MD, on Sequencing, Cost, and the Road to CLL Cure

Real-World Data Show MASH Progresses Faster Than Trials Suggest